These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21763750)

  • 1. The transcription factor FOXL2: at the crossroads of ovarian physiology and pathology.
    Caburet S; Georges A; L'Hôte D; Todeschini AL; Benayoun BA; Veitia RA
    Mol Cell Endocrinol; 2012 Jun; 356(1-2):55-64. PubMed ID: 21763750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mutations and potential targets of the forkhead transcription factor FOXL2.
    Moumné L; Batista F; Benayoun BA; Nallathambi J; Fellous M; Sundaresan P; Veitia RA
    Mol Cell Endocrinol; 2008 Jan; 282(1-2):2-11. PubMed ID: 18155828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of polyalanine expansion mutation and a novel missense substitution in transcription factor FOXL2 leads to different ovarian phenotypes in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) patients.
    Fan J; Zhou Y; Huang X; Zhang L; Yao Y; Song X; Chen J; Hu J; Ge S; Song H; Fan X
    Hum Reprod; 2012 Nov; 27(11):3347-57. PubMed ID: 22926839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxl2 function in ovarian development.
    Uhlenhaut NH; Treier M
    Mol Genet Metab; 2006 Jul; 88(3):225-34. PubMed ID: 16647286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXL2: a central transcription factor of the ovary.
    Georges A; Auguste A; Bessière L; Vanet A; Todeschini AL; Veitia RA
    J Mol Endocrinol; 2014 Feb; 52(1):R17-33. PubMed ID: 24049064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premature ovarian failure and forkhead transcription factor FOXL2: blepharophimosis-ptosis-epicanthus inversus syndrome and ovarian dysfunction.
    De Baere E; Copelli S; Caburet S; Laissue P; Beysen D; Christin-Maitre S; Bouchard P; Veitia R; Fellous M
    Pediatr Endocrinol Rev; 2005 Jun; 2(4):653-60. PubMed ID: 16208278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel protein partners of the transcription factor FOXL2 provides insights into its physiopathological roles.
    L'Hôte D; Georges A; Todeschini AL; Kim JH; Benayoun BA; Bae J; Veitia RA
    Hum Mol Genet; 2012 Jul; 21(14):3264-74. PubMed ID: 22544055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new FOXL2 gene mutation in a woman with premature ovarian failure and sporadic blepharophimosis-ptosis-epicanthus inversus syndrome.
    Corrêa FJ; Tavares AB; Pereira RW; Abrão MS
    Fertil Steril; 2010 Feb; 93(3):1006.e3-6. PubMed ID: 19969293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor FOXL2 protects granulosa cells from stress and delays cell cycle: role of its regulation by the SIRT1 deacetylase.
    Benayoun BA; Georges AB; L'Hôte D; Andersson N; Dipietromaria A; Todeschini AL; Caburet S; Bazin C; Anttonen M; Veitia RA
    Hum Mol Genet; 2011 May; 20(9):1673-86. PubMed ID: 21289058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXL2 mutations lead to different ovarian phenotypes in BPES patients: Case Report.
    Méduri G; Bachelot A; Duflos C; Bständig B; Poirot C; Genestie C; Veitia R; De Baere E; Touraine P
    Hum Reprod; 2010 Jan; 25(1):235-43. PubMed ID: 19819892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential apoptotic and proliferative activities of wild-type FOXL2 and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)-associated mutant FOXL2 proteins.
    Kim JH; Bae J
    J Reprod Dev; 2014 Mar; 60(1):14-20. PubMed ID: 24240106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2.
    Laissue P; Lakhal B; Benayoun BA; Dipietromaria A; Braham R; Elghezal H; Philibert P; Saâd A; Sultan C; Fellous M; Veitia RA
    J Med Genet; 2009 Jul; 46(7):455-7. PubMed ID: 19429596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional study on a novel missense mutation of the transcription factor FOXL2 causes blepharophimosis-ptosis-epicanthus inversus syndrome (BPES).
    Fan JY; Han B; Qiao J; Liu BL; Ji YR; Ge SF; Song HD; Fan XQ
    Mutagenesis; 2011 Mar; 26(2):283-9. PubMed ID: 21068205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of the FOXL2 gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
    Tang S; Wang X; Lin L; Sun Y; Wang Y; Yu H
    Mutagenesis; 2006 Jan; 21(1):35-9. PubMed ID: 16394030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human FOXL2 mutation database.
    Beysen D; Vandesompele J; Messiaen L; De Paepe A; De Baere E
    Hum Mutat; 2004 Sep; 24(3):189-93. PubMed ID: 15300845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXL2: at the crossroads of female sex determination and ovarian function.
    Benayoun BA; Dipietromaria A; Bazin C; Veitia RA
    Adv Exp Med Biol; 2009; 665():207-26. PubMed ID: 20429427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-occurrence of congenital hydronephrosis and FOXL2-associated blepharophimosis, ptosis, epicanthus inversus syndrome (BPES).
    Gulati R; Verdin H; Halanaik D; Bhat BV; De Baere E
    Eur J Med Genet; 2014 Oct; 57(10):576-8. PubMed ID: 25192944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel FOXL2 mutations in two Chinese families with blepharophimosis-ptosis-epicanthus inversus syndrome.
    Xue M; Zheng J; Zhou Q; Hejtmancik JF; Wang Y; Li S
    BMC Med Genet; 2015 Sep; 16():73. PubMed ID: 26323275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential functional effects of novel mutations of the transcription factor FOXL2 in BPES patients.
    Nallathambi J; Laissue P; Batista F; Benayoun BA; Lesaffre C; Moumné L; Pandaranayaka PE; Usha K; Krishnaswamy S; Sundaresan P; Veitia RA
    Hum Mutat; 2008 Aug; 29(8):E123-31. PubMed ID: 18484667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation.
    Beysen D; Moumné L; Veitia R; Peters H; Leroy BP; De Paepe A; De Baere E
    Hum Mol Genet; 2008 Jul; 17(13):2030-8. PubMed ID: 18372316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.